Frank Osterkamp

NEUROTENSIN RECEPTOR LIGANDS

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

CARBONIC ANHYDRASE IX LIGANDS

GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS

FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

NEUROTENSIN RECEPTOR LIGANDS

TFPI inhibitors and methods of use

NPR-B agonists

TFPI inhibitors and methods of use

NPR-B agonists

TFPI inhibitors and methods of use

TFPI inhibitors and methods of use

Conjugate comprising a neurotensin receptor ligand and use thereof

Peptides and methods of use

Cyclic peptide-based NPR-B agonists

NPR-B agonists

Neurotensin receptor ligands

Peptides and methods of use

TFPI inhibitors and methods of use

NPR-B agonists

TFPI inhibitors and methods of use

TFPI inhibitors and methods of use

TFPI inhibitors and methods of use

NPR-B agonists

COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF

Heterocyclic compounds for the inhibition of integrins and use thereof

Compounds for the inhibition of integrins and use thereof

Compounds for the inhibition of angiogenesis and use thereof

Phenol derivatives and their use as rotamase inhibitors

Method for determining the substrate specificity of an enzyme